Amplitude Therapeutics与礼来公司宣布达成战略合作,双方将携手推进针对传染病的自扩增RNA疫苗研发。这一合作标志着两家企业在创新疫苗技术领域迈出重要一步,旨在利用自扩增RNA平台的独特优势,加速应对全球公共卫生挑战。
Amplitude Therapeutics与礼来公司宣布达成战略合作,双方将携手推进针对传染病的自扩增RNA疫苗研发。这一合作标志着两家企业在创新疫苗技术领域迈出重要一步,旨在利用自扩增RNA平台的独特优势,加速应对全球公共卫生挑战。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.